Full metal jacket stenting of the superficial femoral artery: a retrospective review.

BACKGROUND The technique of long segment stenting of the superficial femoral artery (SFA) has been associated with poorer short- and long-term results. The full metal jacket (FMJ) stenting is typically described as long segment continuous stenting of a vessel segment. Initially, this technique was described in percutaneous coronary interventions. However, until recently, FMJ of the SFA has not been studied. We examined our experience with FMJ of the SFA to evaluate the outcomes and the safety of this technique. METHODS Retrospective data were gathered for peripheral angioplasties and stenting for the period between January 2005 and December 2008. The cases involving FMJ stenting of the SFA were identified by angiographic findings and the operative dictations providing the stent data. Selective FMJ stenting of the SFA was performed for the residual stenosis after balloon angioplasty of the SFA because of either dissection or significant recoil. The cases with concomitant iliac artery angioplasty and/or stenting were excluded from the data set for analysis. The variables for the evaluation were primary patency rate, mortality rate, and limb salvage rate, which were stratified on the basis of the risk factors. RESULTS A total of 63 cases involving FMJ stenting of the SFA were identified from the database of 707 patients who had peripheral endovascular interventions between January 2005 and December 2008. Average age of the patients was 70 years (range: 52-104 years, SD: 10.1 years). There were no transatlantic inter-society consensus (TASC) A lesions, 11% (7/63) of the lesions were TASC B, 68% (43/63) were TASC C, and 21% (13/63) were TASC D. The median primary patency rate was 9 months (95% CI: 5.06-12.94). The mortality rate was 4% at 6-month follow-up. The limb salvage rate was 85.7%. In all, 65% (41/63) of the patients were claudicants, whereas 23% (15/63) had intervention for some form of tissue loss (ischemic ulcer, gangrene). Associated infrapopliteal intervention was performed in 15.9% of the patients. Average creatinine level was 1.67 (range: 0.7-10.9, SD: 2.03) and 49% (31/63) of the patients had diabetes. The average 6-month patency rate was 55% (SD: 0.5). Multivariate logistic regression analysis showed that diabetes (OR: 0.33, p = 0.044, 95% CI: 0.11-0.97) and a creatinine level of ≥1.6 (OR: 0.16, p = 0.038, 95% CI: 0.03-0.9) were the independent risk factors for loss of patency in <6 months. CONCLUSION Our experience suggests promising results for the technique of FMJ of the SFA and also that further examination of the technique is warranted.

[1]  T. Jacob,et al.  The Role of the Endovascular Surgeon for Lower Extremity Ischemia , 2004, Acta chirurgica Belgica.

[2]  S. Cheng,et al.  Endovascular Stenting of Superficial Femoral Artery Stenosis and Occlusions: Results and Risk Factor Analysis , 2001, Cardiovascular surgery.

[3]  Martin Schillinger,et al.  Long-Segment SFA Stenting—The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent Fractures , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[4]  J. Mills,et al.  Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. , 2008, Journal of vascular surgery.

[5]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery , 2006 .

[7]  R. Ahmadi,et al.  Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. , 2004, Radiology.

[8]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[9]  Seung‐Jung Park,et al.  Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions. , 2006, The American journal of cardiology.

[10]  Evan J Ryer,et al.  Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. , 2008, Journal of vascular surgery.

[11]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[12]  H. Gurm,et al.  Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. , 2008, European heart journal.

[13]  J. Olin,et al.  High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. , 1997, Journal of vascular surgery.

[14]  A. Colombo,et al.  Long-Term Follow-Up on a Large Cohort of “Full-Metal Jacket” Percutaneous Coronary Intervention Procedures , 2009, Circulation. Cardiovascular interventions.

[15]  A. Lumsden,et al.  Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. , 2008, Journal of vascular surgery.

[16]  P. Serruys,et al.  "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. , 2005, American heart journal.

[17]  A. Cross,et al.  Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. , 1993, Journal of vascular and interventional radiology : JVIR.

[18]  A. Hingorani,et al.  Duplex-guided balloon angioplasty of lower extremity arteries. , 2007, Perspectives in vascular surgery and endovascular therapy.

[19]  S. Katz,et al.  Primary stenting of the superficial femoral and popliteal artery. , 2009, Journal of vascular surgery.

[20]  Angioplasty and Primary Stenting of High-grade, Long-segment Superficial Femoral Artery Disease: Is It Worthwhile? , 2003, Annals of vascular surgery.